Applying Emerging Antiretroviral Data to Clinical Practice: A Case-Based Program
Last Modified: Program Description This comprehensive virtual course is a half-day, case-based program designed to translate emerging data recently presented at the 2026 Conference on Retroviruses and Opportunistic Infections (CROI) into practical clinical decision-making. The course will integrate focused (more…)
HIV and Cardiovascular Disease: Lipids, Inflammation, and More — 2026 Update
Overview Assessment of Needs Cardiovascular risk management in people with HIV (PWH) is rapidly evolving, with growing debate around statin initiation in patients previously considered low risk. This webinar will highlight emerging, practice-changing insights, including the Predicting Risk of Cardiovascular Disease Events (PREVENT) risk score. Updated blood pressure guidance and shifting lipid (more…)
IAS-USA Dialogue Series: Emerging Infections and Health Threats
IAS–USA Dialogues are spirited, timely conversations on the public health, scientific, and clinical aspects of current urgent outbreaks, including seasonal viruses such as influenza, emerging infectious disease threats in the US and around the world, controversies surrounding trustworthy guidance on vaccinations, and other topics of the day. Registration is now open for our (more…)
Emerging Infections and Global Outbreaks: Implications for HIV and Infectious Disease Care in the US
Overview Assessment of Needs Emerging infectious diseases and global outbreaks continue to shape clinical practice, with important implications for the care of people with HIV. Increasing international travel, climate change, antimicrobial resistance, and zoonotic diseases such as ebola have heightened the risk of rapid disease spread and evolving epidemiology. This webinar will (more…)
Current Vaccination Recommendations for Children and Adolescents
Overview Assessment of Needs Vaccination plays a crucial role in preventing disease in children and adolescents. Health care practitioners face escalating challenges in implementing updated vaccine recommendations and addressing vaccine hesitancy and misinformation among patients and their caregivers. Differing recommendations across organizations, the politicization of public health guidance, and widespread misinformation further (more…)
Diagnosis and Management of Non–Kaposi Sarcoma Dermatologic Conditions in People With HIV
Overview Assessment of Needs Dermatologic conditions remain common among people with HIV (PWH) and may present with atypical features, diagnostic uncertainty, or management challenges related to immune status, antiretroviral therapy regimens, and patient comorbidities. This webinar will go beyond Kaposi sarcoma (KS) to review the diagnosis and management of non-KS dermatologic conditions (more…)
Review of Data Presented at the 2026 International AIDS Conference
Overview Assessment of Needs Rapid advances in HIV treatment, prevention, long-acting therapies, cure-related research, and management of comorbidities require clinicians to stay current with emerging evidence. The 2026 International AIDS Conference, to be held in Rio de Janeiro, Brazil, and virtually from July 26 to 31, 2026, will present new data with (more…)
IAS-USA Dialogue Series: Emerging Infections and Health Threats
IAS–USA Dialogues are spirited, timely conversations on the public health, scientific, and clinical aspects of current urgent outbreaks, including seasonal viruses such as influenza, emerging infectious disease threats in the US and around the world, controversies surrounding trustworthy guidance on vaccinations, and other topics of the day. Registration is now open for our (more…)
Herpes Simplex Virus and Varicella Zoster Virus in People With HIV: Prevention and Treatment Strategies
Overview Assessment of Needs People with HIV (PWH) are at increased risk for complications related to herpes simplex virus (HSV) and varicella zoster virus (VZV). This webinar will review current strategies for the prevention, diagnosis, and treatment of HSV and VZV infections in PWH, including antiviral therapies, vaccination recommendations, and management considerations in the (more…)
Clinical Relevance of M184I/V in Current and Future HIV Management
Overview Assessment of Needs The clinical relevance of M184I/V continues to evolve as HIV treatment strategies incorporate dual therapies, archived resistance testing, and novel antiretroviral agents. Clinicians need updated knowledge on the biologic and clinical impact of M184I/V on different antiretroviral regimens, including its effects on viral fitness, (more…)